{
    "symbol": "AZYO",
    "quarter": 4,
    "year": 2022,
    "date": "2023-03-22 18:12:04",
    "content": " We concluded 2022 on a very strong note, posting record annual revenues of $49.2 million, led by robust sales growth of our SimpliDerm and CanGaroo product lines. Our bottom-line results for the fourth quarter of 2022 also included $5 million of other income related to a reduction of the company's revenue interest obligation, which is based on the forecasted timing and extent of net sales for the company's CanGaroo and cardiovascular product lines and the associated revenue and milestone payments."
}